Combinatorial Engineering of Proteolytically Resistant APPI Variants that Selectively Inhibit Human Kallikrein 6 for Cancer Therapy
https://doi.org/10.60705/3dpx/14489.2NIH 3D Model Entry
3DPX-014489How to Cite
Summary Information
Title: Combinatorial Engineering of Proteolytically Resistant APPI Variants that Selectively Inhibit Human Kallikrein 6 for Cancer Therapy
Description:
Creator(s):
Contributor(s):
NIH 3D, Data Manager
Publisher: NIH 3D
Publication Year: 2020
Version: 2.x
"x" corresponds to any minor version